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Background
Until recently, the use of MRI in patients with PPM’s
was prohibited. The lifetime probability of a patient with
a cardiac device requiring an MRI is 50-75%. Serious
adverse events occurring during MRI of patients with
cardiac devices are rare, but include asystole, VF and
death. There is a clinical need to develop knowledge of
MR safe devices and safe scanning protocols.
This study specifically address these issues in the SJM
Accent MR PPM System, undergoing a dedicated CMR
scan at 1.5 T, with a long scan duration at max power.
Methods
Patients were recruited into the MAPS trial and implanted
with a SJM Accent ppm and 2 tendril MR leads. All
patients were PPM dependent. CMR was performed more
than 6 weeks following implant. Pacing capture thresholds,
impedances and battery voltages were assessed prior to,
between and immediately following the CMR scan. The
scans were performed on a Siemens Avanto 1.5T scanner.
All patients were placed in an MR pacing mode. Each scan
duration was over 90 mins.
Results
Between February 2012 and February 2014, 50 patients
were implanted with the SJM MR ppm. The mean age
of the patients was 67.3±8.1 years, 30 male. All 50
patients had at least 1 CMR.
There were no significant adverse events reported dur-
ing any of the scans and no loss of capture was seen in
any scan.
Pacing thresholds
The mean pacing threshold for RVOT lead at implant
was 0.67±0.22V and at 2 week check was 0.73±0.21V.
Pacing thresholds prior to the 1st CMR scan, between
the lead switch over and following the scan were 0.66
±0.16V, 0.66±0.16V and 0.69±0.27V respectively, p=0.34.
The mean pacing threshold for the apical lead at implant
was 0.71±0.29V and at 2 week check was 0.74±0.26V.
Pacing thresholds prior to the 1st CMR scan, between the
lead switch over and following the scan were 0.69±0.17V,
0.69±0.16V and 0.69±0.16V respectively, p= 1.
Impedance
The mean pacing impedance for the RVOT lead at implant
was 739±168Ω and at 2 week check was 655±251Ω. Pacing
impedances prior to the CMR scan, between the lead
switch over and following the scan were 601±123Ω,
595±114Ω and 579±141Ω respectively, p=0.008.
The mean pacing impedance for Apical lead at implant
was 631±130Ω and at 2 week check was 616±81Ω.
Pacing impedances prior to the CMR scan, between the
lead switch over and following the scan were 612±81Ω,
611±80Ω and 574±69Ω respectively, p=0.004.
Battery
The mean battery voltage prior to, between and follow-
ing every CMR scan did not alter acutely. CMR scan 1
was at 2.99±0.03V.
Specific absorption rate
The max SAR of 4 w/kg was never exceeded. See Fig 1.
Tendril leads 5 control patients had the MR system
but no CMR scans. Table 1 compares the parameters
between cohorts over 12 months. A similar trend in
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parameter changes was observed between the CMR and
non-CMR pacing cohort.
Conclusions
Prolonged max power CMR scanning of the St Jude
Accent - Tendril IPG system at 1.5 T is safe and has no
clinically relevant effects on PCT, voltage and Battery
power.
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Figure 1 illustrates the Mean SAR of the different MR sequences for 10 scans.
Table 1 Control group of 5 patients with MR system but
no CMR scans compared to study group.
0 months 2 months 12 months
Threshold (V) Control 0.625 +/-0.14 0.6±04 0.65±0.3
CMR group 0.67±0.16 0.67±0.2 0.7±0.48
Impedance Ω Control 698±135 568±85 537±92
CMR group 739±167 585±108 558±154
Battery (V) Control 2.99 2.99 2.96
CMR group 3 3 2.96
Ainslie et al. Journal of Cardiovascular Magnetic
Resonance 2015, 17(Suppl 1):M6
http://www.jcmr-online.com/content/17/S1/M6
Page 2 of 2
